Package 60505-4852-3

{"route": ["ORAL"], "spl_id": "ff96d3ff-6a1c-2545-b939-f383e0262179", "openfda": {"nui": ["N0000175729", "N0000175651", "N0000175769"], "unii": ["R3UK8X3U3D"], "rxcui": ["205324", "213471", "226426", "260218"], "spl_set_id": ["0391f182-1958-9fef-a944-53b229ce99e7"], "pharm_class_pe": ["Central Nervous System Stimulation [PE]", "Increased Sympathetic Activity [PE]"], "pharm_class_epc": ["Sympathomimetic-like Agent [EPC]"], "manufacturer_name": ["Apotex Corp"], "is_original_packager": [true]}, "finished": true, "packaging": [{"sample": false, "description": "30 TABLET in 1 BOTTLE (60505-4852-3)", "package_ndc": "60505-4852-3", "marketing_start_date": "20250831"}], "brand_name": "Provigil", "product_id": "60505-4852_ff96d3ff-6a1c-2545-b939-f383e0262179", "dosage_form": "TABLET", "pharm_class": ["Central Nervous System Stimulation [PE]", "Increased Sympathetic Activity [PE]", "Sympathomimetic-like Agent [EPC]"], "product_ndc": "60505-4852", "dea_schedule": "CIV", "generic_name": "Modafinil", "labeler_name": "Apotex Corp", "product_type": "HUMAN PRESCRIPTION DRUG", "brand_name_base": "Provigil", "active_ingredients": [{"name": "MODAFINIL", "strength": "200 mg/1"}], "application_number": "NDA020717", "marketing_category": "NDA", "marketing_start_date": "20250831", "listing_expiration_date": "20261231"}